Evidence map›Paper›PMID 22340259›Full record

ArticleFEMS immunology and medical microbiology2012

Human platelets efficiently kill IgG-opsonized E. coli.

Anum H Riaz, Brian E Tasma, Michael E Woodman, R Mark Wooten, Randall G Worth

Abstract read
In one paragraph

Article in FEMS immunology and medical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Supernatant of platelet-Microbiology spectrum · 2024
    Article
  6. An Insight into Recent Advances on Platelet Function in Health and Disease.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Effect of antiplatelet agents onFrontiers in microbiology · 2022
    Review
  9. Article
  10. Review
  11. Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword.International journal of molecular sciences · 2021
    Review
  12. The role of platelets in sepsis.Research and practice in thrombosis and haemostasis · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Platelets PromoteFrontiers in immunology · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anum H RiazDepartment of Medical Microbiology & Immunology, University of Toledo College of Medicine, Toledo, OH 43614, USA.
Brian E Tasma
Michael E Woodman
R Mark Wooten
Randall G Worth
University of Toledo · US

Funding

Dysregulation of Innate Immune Responses by Borrelia burgdorferi:A Role for IL-10R01AI073452 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WOOTEN, RONALD MARK · 2008 to 2011
$1.5M
NIAID NIH HHS 1R01 AI073452NIAID NIH HHS R01 AI073452
6 · The paper itself

Abstract

Platelets are known contributors of hemostasis but have recently been shown to be important in inflammation and infectious diseases. Moreover, thrombocytopenia is often observed in patients with sepsis. We previously reported that platelets actively phagocytosed IgG-coated latex beads. In this study, the capacity of human platelets to participate in host defense against bacterial infections was determined by assessing their ability to kill Escherichia coli. Washed human platelets were incubated with unopsonized or IgG-opsonized E. coli and evaluated for binding and killing of E. coli. We found that although both unopsonized and IgG-opsonized E. coli were associated with platelets, only IgG-opsonized E. coli were efficiently killed unless platelets were activated by a potent agonist. The bactericidal activity was dependent on FcγRIIA, was sensitive to cytochalasin D, but was not due to reactive oxygen metabolites. These data suggest that platelets may play an important role in protection against infection.

Indexed as

Microbial ViabilityAntibodies, BacterialBacterial AdhesionBlood PlateletsCytochalasin DEscherichia coliHumansImmunoglobulin GOpsonin ProteinsReactive Oxygen SpeciesReceptors, IgGAntibodies, BacterialCytochalasin DFc gamma receptor IIAImmunoglobulin GOpsonin ProteinsReactive Oxygen SpeciesReceptors, IgG

Identifiers

PMID22340259
PMCPMC3342444
OpenAlexW2022065904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.